Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023

/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its consolidated results for...

Related Keywords

Germany ,Mumbai ,Maharashtra ,India ,Nandini Piramal ,Piramal Pharma ,Contract Development ,Hemmo Pharmaceuticals Pvt Ltd ,Twitter ,Piramal Pharma Limited ,Piramal Pharma Ltd ,Carlyle Group ,Manufacturing Organization ,Piramal Pharma Solutions ,Allergan ,Facebook ,Convergence Chemical Pvt Ltd ,Piramal Enterprises Ltd ,Second Quarter ,Half Year ,Hospital Generic ,Consumer Healthcare ,Business Highlights ,Hospital Generics ,Inhalation Anesthesia ,Pre Filled Syringe ,Lacto Calamine ,Deferred Tax Assets ,Pharma Limited ,Piramal Critical Care ,Complex Hospital Generics ,India Consumer Healthcare ,Indian Consumer Healthcare ,